TrialHepatology (Baltimore, Md.)2012

Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.

Maureen M Jonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.